S&P/ASX All Ords Index (ASX: XAO) shares are down 3% over 12 months.
On The Bull this week, Mark Gardner from MPC Markets shares his insights on three stocks.
Image source: Getty Images
Greatland Resources Ltd (ASX: GGP)
The Greatland Resources share price is up 40% over 12 months.
Gardner has a buy call on this ASX gold mining share.
He said:
Greatland is moving into mid-tier gold and copper production.
GGP produced 328,987 ounces of gold and 14,594 tonnes of copper in full year 2026. The company beat production and cost guidance.
Net profit after tax of $862 million was up 156 per cent on the prior corresponding period.
The shares have fallen on weaker production guidance in full year 2027.
GGP offers an appealing entry price. In our view, the market is too focused on a weaker guidance rather than funded growth.
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price is up 7% over 12 months.
Gardner has a hold rating on this ASX healthcare share.
He explained:
The US Food and Drug Administration recently approved the company's brain cancer imaging drug Pixclara.
TLX shares soared on the news, but we believe the approval is largely priced in at this point.
However, the underlying business is in good shape. Group revenue of $US477 million in the first half of 2026 was up 22 per cent on the prior corresponding period.
The group gross margin of 55 per cent was up 2 per cent year-on year. The company maintained a cash balance of $US252 million at June 30, 2026.
Qualitas Ltd (ASX: QAL)
The Qualitas share price is down 34% over 12 months.
Gardner has a sell recommendation on this ASX financial share.
He commented:
Qualitas is an alternative real estate investment manager with about $11.6 billion of committed funds under management at June 30, 2026.
QAL manages investments across real estate private credit and real estate private equity via a range of investment solutions for institutional, wholesale and retail clients.
The company has exposure to construction lending in a sector we believe is under pressure from rising costs amid potentially higher interest rates.
The shares have fallen from $3.36 on August 13 to trade at $2.38 on September 24.
We would rather be on the sidelines until credit costs stop rising.
